CN113292393A - Method for synthesizing alpha, alpha-dideuterol and deuterated drugs by reducing and deuterating acyl fluoride compounds - Google Patents

Method for synthesizing alpha, alpha-dideuterol and deuterated drugs by reducing and deuterating acyl fluoride compounds Download PDF

Info

Publication number
CN113292393A
CN113292393A CN202110412855.5A CN202110412855A CN113292393A CN 113292393 A CN113292393 A CN 113292393A CN 202110412855 A CN202110412855 A CN 202110412855A CN 113292393 A CN113292393 A CN 113292393A
Authority
CN
China
Prior art keywords
compound
alpha
dideuterol
general formula
deuterated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110412855.5A
Other languages
Chinese (zh)
Inventor
方冰
李恒朝
彭梦琪
宁磊
陈星月
安杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Agricultural University
Original Assignee
China Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Agricultural University filed Critical China Agricultural University
Priority to CN202110412855.5A priority Critical patent/CN113292393A/en
Publication of CN113292393A publication Critical patent/CN113292393A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001Acyclic or carbocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/093Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/04Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
    • C07C209/06Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms
    • C07C209/08Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/58Preparation of carboxylic acid halides
    • C07C51/60Preparation of carboxylic acid halides by conversion of carboxylic acids or their anhydrides or esters, lactones, salts into halides with the same carboxylic acid part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/14Preparation of carboxylic acid esters from carboxylic acid halides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/31Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/70Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to an alpha, alpha-dideuterol compound and a reduction deuteration method of an acyl fluoride compound for preparing the alpha, alpha-dideuterol compound, which is characterized in that the acyl fluoride compound shown in a general formula (1) reacts with a bivalent lanthanide series transition metal compound and a deuterium donor reagent in an organic solvent I to generate the alpha, alpha-dideuterol compound shown in a general formula (2). The invention provides a reduction deuteration method of acyl fluoride compounds based on single electron transfer reduction deuteration reaction, which solves the problems of using flammable reducing agent, poor selectivity, poor atom economy and the like in the preparation of alpha, alpha-dideuterol compounds in the prior art. The method can be used for preparing the alpha, alpha-dideuterol compounds and has the advantages of high deuteration rate of the product, good zone selectivity, good chemical selectivity, low reagent price, simple operation, mild condition and wide application range of the substrate.

Description

Method for synthesizing alpha, alpha-dideuterol and deuterated drugs by reducing and deuterating acyl fluoride compounds
Technical Field
The invention relates to alpha, alpha-dideuterol, a deuterated drug and a reduction deuteration method of an acyl fluoride compound for synthesizing the alpha, alpha-dideuterol compound.
Background
Deuterated organic compounds are widely used in the fields of life science, material science, instrument analysis, organic reaction mechanism research and the like. Because of the kinetic isotope effect (DKIE), the C-D bond is more stable, and deuterium introduced into a drug molecule can improve the kinetic characteristics of the drug, reduce metabolic toxicity and improve the activity of the drug. The research and development of deuterated drugs gradually become a hot field. Alcohol compounds and their derivatives are important fragments for the synthesis of many active compounds. The synthesis of deuterium labeled drugs and other active molecules is of great significance for the metabolism and toxicological studies of drugs and the development of new drugs. Therefore, the synthesis of the alpha, alpha-dideuterol compounds is of great significance to the research and development of deuterated drugs.
The synthesis of α, α -dideuterol mainly uses the introduction of deuterium into a specific position in the molecule by reducing deuterated carboxylic acids and their derivatives, the conventional reductive deuteration using metal deuterides (e.g. NaBD)4And LiAlD4) As a reducing agent, the reaction has the advantages of high deuteration rate, good regioselectivity and the like, but metal deuterides are expensive and flammable, and the application range of the reaction is limited (Molecules,2015,20(9): 16741). In contrast, the one-electron transfer reduction of deuterated esters to synthesize α, α -dideuterol is a more attractive strategy, allowing higher deuteration rates and good regioselectivity to be achieved using less expensive reagents and relatively safe conditions. However, recently reported alkali/deuterated alcohols and Smi2/D2O/Et3N reduction deuteration systems (j.org.chem.2017,82,1285, chem.commun.2011,47,10254.) have mild conditions and high deuteration rate, but the reduction capability of the systems is strong, and many sensitive groups are, for example: halogen, olefinic bond, acetylene bond, cyano and the like are reduced, and the selectivity of the reaction is poor. Reported in our as Smi2/D2In the method for selectively synthesizing alpha, alpha-dideuterol by reducing deuterated pentafluorophenol ester by using O as a medium, sensitive functional groups are not reduced, so that a novel method is provided for synthesizing alpha, alpha-dideuterol with various functional groups. However, pentafluorophenol ester as a carboxylic acid derivative is reductively deuterated to produce α, α -dideuterol, which is a reaction atom less economical, and pentafluorophenol as a by-product is produced. As carboxylic acid derivatives, reductive deuteration of acyl fluorides to α, α -dideuterol has never been reported, and the atom economy is greatly improved in comparison. Therefore, the development is more efficientThe reaction of selective formation of alpha, alpha-dideuterol by reductive deuteration of an economical carboxylic acid derivative is extremely important.
Disclosure of Invention
The technical problem to be solved by the present invention is to provide
The invention provides a reduction deuteration method of acyl fluoride compounds based on single electron transfer reduction deuteration reaction, which aims to solve the problems of using flammable reducing agent, poor selectivity, poor atom economy and the like in the preparation of alpha, alpha-dideuterol compounds in the prior art. The method can be used for preparing the alpha, alpha-dideuterol compounds and has the advantages of high deuteration rate of the product, good zone selectivity, good chemical selectivity, low reagent price, simple operation, mild condition and wide application range of the substrate.
The synthesis method of the alpha, alpha-dideuterol compound shown in the general formula (2) is characterized in that the acyl fluoride compound shown in the general formula (1) reacts with a bivalent lanthanide series transition metal compound and a deuterium donor reagent in an organic solvent I to generate the alpha, alpha-dideuterol compound shown in the general formula (2);
Figure BDA0003024805710000021
in the general formula (1), R1Selected from substituted or unsubstituted alkyl, substituted or unsubstituted aryl; r1Wherein the substituent is alkyl, halogen, alkoxy, alkylthio, trifluoroalkyl and ester group.
The deuterium donor agent is selected from deuterium oxide, deuterated alcohol or mixtures thereof.
A method for synthesizing alpha, alpha-dideuteroalcohol compounds represented by the general formula (2) is characterized by comprising the following steps:
step 1: after argon protection is carried out on the reactor, constant temperature treatment is carried out, and organic solvent I is added to prepare divalent lanthanide series transition metal compound solution;
step 2: preparing a solution from an acyl fluoride compound and an organic solvent I, and adding the solution into a reactor;
and step 3: adding a deuterium donor reagent to the reactor;
and 4, step 4: stirring the mixed solution for a certain time, and then quenching the reaction;
and 5: adding an organic solvent II and an acid solution for extraction, drying and concentrating an organic phase, and purifying to obtain a compound with a general formula (2);
preferably, in step 1, the reactor is a round-bottom flask;
preferably, in step 1 and step 2, the same organic solvent is used;
preferably, in step 3, a quantitative amount of deuterium donor reagent is added to the reactor under constant temperature conditions;
preferably, in step 4, the stirring is vigorous stirring;
preferably, in step 4, the quenching reaction is carried out by introducing air;
preferably, the step 5 is adding ethyl acetate and hydrogen chloride solution (1M) for extraction, drying and concentrating the organic phase, and performing column chromatography to obtain the compound of the general formula (2)
The deuterium donor agent is selected from deuterium oxide, deuterated alcohol or mixtures thereof;
preferably, the deuterated alcohol is one in which the hydroxyl group is deuterated;
preferably, the deuterium donor reagent is heavy water (D)2O), deuterated methanol (MeOD), deuterated ethanol (EtOD), deuterated n-propanol (n-PrOD), deuterated isopropanol (i-PrOD), deuterated n-butanol (n-BuOD) and deuterated tert-butanol (t-BuOD);
more preferably, the deuterium donor reagent is heavy water (D)2O)。
The divalent lanthanide transition metal compound is selected from one or the combination of more than two of a divalent samarium compound, a divalent dysprosium compound, a divalent neodymium compound, a divalent ytterbium compound, a divalent cerium compound and a divalent europium compound;
preferably, the divalent lanthanide transition metal compound is selected from samarium diiodide (SmI)2) Dysprosium diiodide (DyI)2) Neodymium diiodide (NdI)2) Ytterbium diiodide (YbI)2) Cerium diiodide (CeI)2) And europium (II) perchlorate (Eu (ClO)4)2) One or two or more kinds ofCombining;
preferably, the divalent lanthanide transition metal compound is samarium diiodide (SmI)2)。
The organic solvent I is selected from one or the combination of more than two of micromolecular alkane, naphthenic hydrocarbon, aromatic hydrocarbon, ether and cyclic ether solvents;
preferably, the organic solvent I is one or a combination of more than two of n-hexane, n-pentane, hexane, cyclohexane, toluene, diethyl ether, tetrahydrofuran, 2-methyltetrahydrofuran and dioxane;
preferably, the organic solvent I is tetrahydrofuran.
The ratio of the organic solvent I to the acyl fluoride compound is 1 mL: 1-300 mg.
The reaction temperature is-40 to 60 ℃; the reaction time is 0.1-60 min.
Deuterated cinacalcet and deuterated 2, 4-D-2-ethylhexyl ester synthesized by using alpha, alpha-dideuterol compounds shown as a general formula (2) as raw materials.
Preferably, the α, α -dideuteroalcohol compound represented by the general formula (2) is characterized in that: the following specific formula (2) compound, preferably the following specific formula (2) compound:
Figure BDA0003024805710000041
Detailed Description
The following examples are given to further illustrate the embodiments of the present invention.
Example 1
Figure BDA0003024805710000042
To a 100mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)50.0mL of a solution in tetrahydrofuran (0.100mol/L), 150mg (1.00mmol) of Compound 1a, and 601mg (30.0mmol) of heavy water. The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reactionShould be used. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 131mg of a target compound 2a, wherein the yield is 95%, and the deuteration rate is more than 98%.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2a obtained by adopting the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ7.33–7.24(m,2H),7.21–7.16(m,3H),2.71(t,J=7.7Hz,2H),1.88(t,J=7.7Hz,2H),1.43(br,1H);13C{1H}NMR(126MHz,CDCl3)δ141.9,128.5(×2),125.9,61.6(m),34.1,32.1.
example 2
Figure BDA0003024805710000051
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)15.0mL of a solution in tetrahydrofuran (0.100mol/L), 54.7mg (0.300mmol) of Compound 1b, and 180mg (9.00mmol) of heavy water. The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 49.5mg of a target compound 2b, wherein the yield is 98%, and the deuteration rate is more than 98%.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2b obtained by adopting the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ7.11(m,2H),6.83(m,2H),3.78(s,3H),2.64(t,J=7.7Hz,2H),1.84(t,J=7.7Hz,2H),1.70(br,1H);13C{1H}NMR(126MHz,CDCl3)δ157.8,133.9,129.4,113.9,61.5(m),55.3,34.3,31.1.
example 3
Figure BDA0003024805710000052
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2) Solution in tetrahydrofuran (0.100mol/L)15.0mL, Compound1c 49.9mg (0.300mmol), 180mg (9.00mmol) of heavy water. The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 44.8mg of a target compound 2c, wherein the yield is 98 percent, and the deuteration rate is 98 percent.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2c obtained by adopting the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ7.11–7.07(m,4H),2.66(t,J=7.8Hz,2H),2.31(s,3H),1.85(t,J=7.8Hz,2H),1.65(br,1H);13C{1H}NMR(126MHz,CDCl3)δ138.8,135.4,129.1,128.4,61.6(m),34.2,31.6,21.0.
example 4
Figure BDA0003024805710000053
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)15.0mL of a solution in tetrahydrofuran (0.100mol/L), 51.1mg (0.300mmol) of the compound 1d, and 180mg (9.00mmol) of heavy water. The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 45.9mg of a target compound 2d, wherein the yield is 98% and the deuteration rate is 98%.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2d obtained by adopting the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ7.14(m,2H),6.96(m,2H),2.68(t,J=7.8Hz,2H),1.85(t,J=7.8Hz,2H),1.51(br,1H);13C{1H}NMR(126MHz,CDCl3)δ161.3(d,JC-F=243.5Hz),137.5(d,JC-F=2.9Hz),129.8(d,JC-F=7.5Hz),115.2(d,JC-F=21.1Hz),61.4(m),34.2,31.2.
example 5
Figure BDA0003024805710000061
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)15.0mL of a solution in tetrahydrofuran (0.100mol/L), 56.0mg (0.300mmol) of compound 1e, and 180mg (9.00mmol) of heavy water. The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 50.2mg of a target compound 2e, wherein the yield is 97%, and the deuteration rate is 98%.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2e obtained by adopting the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ7.24(m,2H),7.12(m,2H),2.67(t,J=7.7Hz,2H),1.84(t,J=7.7Hz,2H),1.62(br,1H);13C{1H}NMR(126MHz,CDCl3)δ140.3,131.6,129.8,128.5,61.3(m),33.9,31.4.
example 6
Figure BDA0003024805710000062
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)15.0mL of a solution in tetrahydrofuran (0.100mol/L), 69.3mg (0.300mmol) of the compound 1f, and 180mg (9.00mmol) of heavy water. The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 62.5mg of a target compound 2f, wherein the yield is 96 percent, and the deuteration rate is 98 percent.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2f obtained by the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ7.39(m,2H),7.07(m,2H),2.65(t,J=7.7Hz,2H),1.84(t,J=7.7Hz,2H),1.67(br,1H);13C{1H}NMR(126MHz,CDCl3)δ140.8,131.5,130.3,119.6,61.3(m),33.8,31.4.
example 7
Figure BDA0003024805710000071
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)15.0mL of a solution in tetrahydrofuran (0.100mol/L), 84.4mg (0.300mmol) of the compound 1g, and 180mg (9.00mmol) of heavy water. The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 80.1mg of a target compound 2g, wherein the yield is 96 percent, and the deuteration rate is 98 percent.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on 2g of the target product obtained by the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ7.59(m,2H),6.95(m,2H),2.65(t,J=7.7Hz,2H),1.84(t,J=7.7Hz,2H),1.62(br,1H);13C{1H}NMR(126MHz,CDCl3)δ141.5,137.5,130.6,90.9,61.5(m),33.8,31.6.
example 8
Figure BDA0003024805710000072
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)15.0mL of a solution in tetrahydrofuran (0.100mol/L), 1h 59.5mg (0.300mmol) of the compound, and 180mg of heavy water (9.00 mmol). The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 54.2mg of a target compound, namely the target compound for 2h, wherein the yield is 98 percent, and the deuteration rate is 98 percent.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2h obtained by adopting the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ7.20(m,2H),7.12(m,2H),2.66(t,J=7.7Hz,2H),2.46(s,3H),1.84(t,J=7.7Hz,2H),1.67(br,1H);13C{1H}NMR(126MHz,CDCl3)δ139.0,135.4,129.0,127.2,61.4(m),34.0,31.5,16.4.
example 9
Figure BDA0003024805710000081
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)15.0mL of a solution in tetrahydrofuran (0.100mol/L), 58.3mg (0.300mmol) of Compound 1i, and 180mg (9.00mmol) of heavy water. The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 37.9mg of a target compound 2i, wherein the yield is 70%, and the deuteration rate is more than 98%.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2i obtained by adopting the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ7.33(m,2H),7.15(m,2H),2.80(s,2H),1.86(br,1H),1.30(s,9H);13C{1H}NMR(126MHz,CDCl3)δ149.3,135.4,128.7,125.5,62.9(m),38.5,34.4,31.4.
example 10
Figure BDA0003024805710000082
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)15.0mL of a solution in tetrahydrofuran (0.100mol/L), 46.2mg (0.300mmol) of the compound 1j, and 180mg (9.00mmol) of heavy water. The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 41.2mg of a target compound 2j, wherein the yield is 98%, and the deuteration rate is more than 98%.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2j obtained by the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ7.27(m,2H),6.89(m,2H),3.80(s,3H),1.84(br,1H);13C{1H}NMR(126MHz,CDCl3)δ159.3,133.1,128.7,114.0,64.4(m),55.4.
example 11
Figure BDA0003024805710000091
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)15.0mL of a solution in tetrahydrofuran (0.100mol/L), 51.1mg (0.300mmol) of compound 1k, and 180mg (9.00mmol) of heavy water. The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 42.2mg of a target compound 2k, wherein the yield is 90%, and the deuteration rate is more than 98%.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2k obtained by adopting the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ7.39–7.08(m,4H),2.48(s,3H),1.76(br,1H);13C{1H}NMR(126MHz,CDCl3)δ137.9,137.7,127.7,126.9,64.3(m),16.0.
example 12
Figure BDA0003024805710000092
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)15.0mL of a solution in tetrahydrofuran (0.100mol/L), 50.2mg (0.300mmol) of the compound 1L, and 180mg (9.00mmol) of heavy water. The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M sodium hydroxide solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 41.4mg of a target compound 2l, wherein the yield is 90%, and the deuteration rate is more than 98%.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2l obtained by the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ7.24(m,2H),6.72(m,2H),2.94(s,6H),1.61(br,1H);13C{1H}NMR(126MHz,CDCl3)δ150.4,128.9,128.7,112.7,64.7(m),40.7.
example 13
Figure BDA0003024805710000093
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)15.0mL of a solution in tetrahydrofuran (0.100mol/L), 54.7mg (0.300mmol) of the compound 1m, and 180mg (9.00mmol) of heavy water. The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 49.5mg of a target compound 2M, wherein the yield is 98% and the deuteration rate is 98%.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2m obtained by adopting the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ1.99(m,3H),1.75–1.72(m,3H),1.67–1.63(m,3H),1.51(m,6H),1.41(br,1H);13C NMR(126MHz,CDCl3)δ73.1(m),39.1,37.3,34.4,28.2.
example 14
Figure BDA0003024805710000101
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)15.0mL of a solution in tetrahydrofuran (0.100mol/L), 55.3mg (0.300mmol) of the compound 1n, and 180mg (9.00mmol) of heavy water. The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 50.1mg of a target compound 2n, wherein the yield is 98%, and the deuteration rate is more than 98%.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2n obtained by adopting the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ2.18(td,J=7.1,2.6Hz,2H),1.94(t,J=2.6Hz,1H),1.63(br,1H),1.58–1.48(m,4H),1.41–1.27(m,10H);13C{1H}NMR(126MHz,CDCl3)δ84.8,68.1,62.3(m),32.6,29.5,29.4,29.1,28.8,28.5,25.7,18.4.
example 15
Figure BDA0003024805710000102
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)15.0mL of a solution in tetrahydrofuran (0.100mol/L), 1o 57.1mg (0.300mmol) of the compound, and 180mg of heavy water (9.00 mmol). The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain a target compound 2o of 42.3mg, wherein the yield is 80%, and the deuteration rate is 98%.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2o obtained by adopting the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ3.67(s,3H),2.31(t,J=7.5Hz,2H),1.63(m,2H),1.54(m,2H),1.37–1.32(m,6H);13C{1H}NMR(126MHz,CDCl3)δ174.4,62.2(m),51.5,34.1,32.5,29.1(×2),25.5,24.9.
example 16
Figure BDA0003024805710000111
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)15.0mL of a solution in tetrahydrofuran (0.100mol/L), 77.5mg (0.300mmol) of Compound 1p, and 180mg (9.00mmol) of heavy water. The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 68.2mg of a target compound 2p, wherein the yield is 93 percent and the deuteration rate is 98 percent.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2p obtained by the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ1.55(t,J=7.2Hz,2H),1.36–1.23(m,26H),0.88(t,J=6.9Hz,3H);13C{1H}NMR(126MHz,CDCl3)δ62.4(m),32.7,32.0,29.8(×4),29.7(×4),29.5(×2),25.8,22.8,14.2.
example 17
Figure BDA0003024805710000112
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)15.0mL of a solution in tetrahydrofuran (0.100mol/L), 85.3mg (0.300mmol) of the compound 1q, and 180mg (9.00mmol) of heavy water. The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 77.1mg of a target compound 2q, wherein the yield is 95% and the deuteration rate is 98%.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2q obtained by adopting the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ5.35(m,2H),2.01(m,4H),1.55(m,2H),1.45–1.13(m,22H),0.88(t,J=6.9Hz,3H);13C{1H}NMR(126MHz,CDCl3)δ130.0,129.9,62.3(m),32.7,32.0,29.8(×2),29.6(×2),29.5,29.4(×2),29.3,27.3(×2),25.2,22.8,14.2.
example 18
Figure BDA0003024805710000121
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)15.0mL of a solution in tetrahydrofuran (0.100mol/L), 50.4mg (0.300mmol) of the compound 1r, and 180mg (9.00mmol) of heavy water. The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.0Extracting with 0M hydrochloric acid solution, drying the organic phase, concentrating, and separating by column chromatography to obtain target compound 2r 41.6mg with yield of 90% and deuteration rate of more than 98%.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2r obtained by adopting the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ6.87(m,1H),6.83–6.77(m,2H),5.95(s,2H),1.71(br,1H);13C{1H}NMR(126MHz,CDCl3)δ147.9,147.2,134.8,120.6,108.3,108.0,101.1,64.7(m).
example 19
Figure BDA0003024805710000122
To a 50mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)15.0mL of a solution in tetrahydrofuran (0.100mol/L), 62.5mg (0.300mmol) of the compound 1s, and 180mg (9.00mmol) of heavy water. The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 52.5mg of a target compound, namely the target compound for 2s, wherein the yield is 90%, and the deuteration rate is more than 98%.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2s obtained by adopting the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ7.15–7.10(m,4H),2.92(q,J=7.0Hz,1H),2.45(d,J=7.2Hz,2H),1.85(m,1H),1.60(br,1H),1.26(d,J=7.1Hz,3H),0.90(d,J=6.6Hz,6H);13C{1H}NMR(126MHz,CDCl3)δ140.8,140.2,129.5,127.2,68.1(m),45.1,41.9,30.3,22.5,17.7.
example 20
Figure BDA0003024805710000131
To a 100mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2) Solution in tetrahydrofuran (0.100 m)ol/L)50.0mL, compound 1t 220mg (1.00mmol), and heavy water 601mg (30.0 mmol). The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 202mg of a target compound 2t, wherein the yield is 98 percent, and the deuteration rate is 98 percent.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2t obtained by adopting the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ7.47–7.42(m,2H),7.41–7.38(m,2H),2.77(t,J=7.8Hz,2H),1.89(t,J=7.8Hz,2H),1.75(br,1H);13C{1H}NMR(126MHz,CDCl3)δ142.8,131.9,130.8(q,JC-F=32.1Hz),128.9,125.2(q,JC-F=4.1Hz),124.3(q,JC-F=272.1Hz),122.8(q,JC-F=3.9Hz),61.2(m),33.8,31.9.
example 21
Figure BDA0003024805710000132
To a 100mL single neck round bottom flask under argon protection was added samarium diiodide (SmI)2)50.0mL of a solution in tetrahydrofuran (0.100mol/L), 1u 146mg (1.00mmol) of the compound, and 601mg of heavy water (30.0 mmol). The reaction mixture was stirred at room temperature for 30.0min, after which air was passed in to quench the reaction. Adding ethyl acetate and 1.00M hydrochloric acid solution for extraction, drying and concentrating an organic phase, and performing column chromatography separation to obtain 119mg of a target compound 2u, wherein the yield is 90%, and the deuteration rate is more than 98%.
The nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection is carried out on the target product 2u obtained by the synthesis method, and the test results are as follows:1H NMR(500MHz,CDCl3)δ1.42–1.25(m,9H),0.90(t,J=6.8Hz,6H);13C{1H}NMR(126MHz,CDCl3)δ64.7(m),41.9,30.2,29.2,23.4,23.2,14.2,11.2.
application examples
Partial hydrogen atoms in the commercial drug are deuterated to form a deuterated drug, and the deuterated drug is important for drug consistency evaluation, drug metabolism research and drug residue detection. To illustrate the practical application of the α, α -dideuterol compound of claim 8, the following deuterated drugs were synthesized by using α, α -dideuterol as a synthesis block.
Application example 1
With reference to the reported non-deuterated drug synthesis method (org. Lett.2019,21,65-69), the deuterated drug Cinacalcet ((+ -.) Cinacalcet-d can be synthesized by taking 2t as a synthesis block2)。
Figure BDA0003024805710000141
Deuterated cinacalcet
The synthetic route for deuterated cinacalcet is as follows:
Figure BDA0003024805710000142
the synthesized deuterated drugs are subjected to nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection, and the test results are as follows:1H NMR(500MHz,CDCl3)δ10.50(br,1H),9.97(br,1H),8.22(d,J=7.2Hz,1H),8.00–7.87(m,3H),7.65–7.53(m,3H),7.31(m,1H),7.24(m,1H),7.21–7.17(m,2H),5.21(m,1H),2.54(m,2H),2.25(m,2H),1.97(d,J=6.7Hz,3H);13C{1H}NMR(126MHz,CDCl3)δ140.9,133.9,132.2,131.6,130.8,130.7(q,JC-F=32.0Hz),129.6,129.5,128.9,127.4,126.3,126.2,125.0,124.95(q,JC-F=3.7Hz),124.0(q,JC-F=272.3Hz),123.1(q,JC-F=4.0Hz),121.3,53.5,44.9(m),32.5,27.1,21.4.
application example 2
Reference is made to the reported synthetic methods of non-deuterated drugs (j. org. chem.2014,79,6743.)
2u is taken as a synthesis building block to synthesize the deuterated drug 2, 4-D-2-ethylhexyl ester (2, 4-D-ethylhexyl ester-D)2)。
Figure BDA0003024805710000143
2, 4-Di-2-ethylhexyl ester
The synthetic route of deuterated 2, 4-d-2-ethylhexyl ester is as follows:
Figure BDA0003024805710000151
the synthesized deuterated drugs are subjected to nuclear magnetic resonance hydrogen spectrum and carbon spectrum detection, and the test results are as follows:1H NMR(500MHz,CDCl3)δ7.40(m,1H),7.16(dd,J=8.7,2.6Hz,1H),6.77(m,1H),4.70(s,2H),1.56(m,1H),1.27–1.21(m,8H),0.89–0.84(m,6H);13C{1H}NMR(126MHz,CDCl3)δ168.4,152.5,130.4,127.6,127.1,124.3,114.5,67.3(m),66.4,38.6,30.3,29.8,29.0,23.7,14.1,11.0.
the above description of the embodiments is only intended to facilitate the understanding of the method of the invention and its core idea. It should be noted that, for those skilled in the art, it is possible to make various improvements and modifications to the present invention without departing from the principle of the present invention, and those improvements and modifications also fall within the scope of the claims of the present invention.

Claims (9)

1. A synthesis method of alpha, alpha-dideuterol compounds shown in a general formula (2) is characterized in that acyl fluoride compounds shown in the general formula (1) react with bivalent lanthanide series transition metal compounds and deuterium donor reagents in an organic solvent I to generate alpha, alpha-dideuterol compounds shown in the general formula (2);
Figure FDA0003024805700000011
in the general formula (1), R1Selected from substituted or unsubstituted alkyl, substituted or unsubstituted aryl; r1Wherein the substituent is alkyl, halogen, alkoxy, alkylthio, trifluoroalkyl and ester group;
the deuterium donor agent is selected from deuterium oxide, deuterated alcohol or mixtures thereof.
2. The method of claim 1, wherein the method comprises the steps of:
step 1: after argon protection is carried out on the reactor, constant temperature treatment is carried out, and organic solvent I is added to prepare divalent lanthanide series transition metal compound solution;
step 2: preparing a solution from an acyl fluoride compound and an organic solvent I, and adding the solution into a reactor;
and step 3: adding a deuterium donor reagent to the reactor;
and 4, step 4: stirring the mixed solution for a certain time, and then quenching the reaction;
and 5: adding an organic solvent II, extracting with an acid solution, drying and concentrating an organic phase, and purifying to obtain a compound of a general formula (2);
preferably, in step 1, the reactor is a round-bottom flask;
preferably, in step 1 and step 2, the same organic solvent is used;
preferably, in step 3, a quantitative amount of deuterium donor reagent is added to the reactor under constant temperature conditions;
preferably, in step 4, the stirring is vigorous stirring;
preferably, in step 4, the quenching reaction is carried out by introducing air;
preferably, in step 5, ethyl acetate and hydrogen chloride solution (1M) are added for extraction, and the organic phase is dried, concentrated and subjected to column chromatography to obtain the compound of the general formula (2).
3. The method for synthesizing α, α -dideuterol compounds represented by general formula (2) according to claim 1, wherein said deuterium donor agent is selected from deuterium oxide, deuterated alcohol, or a mixture thereof;
preferably, the deuterated alcohol is one in which the hydroxyl group is deuterated;
preferably, the deuterium donor reagent is heavy water (D)2O), deuterated methanol (MeOD), deuterated ethanol (EtOD), deuteriumOne or more of n-propanol (n-PrOD), deuterated isopropanol (i-PrOD), deuterated n-butanol (n-BuOD) and deuterated tert-butanol (t-BuOD) are substituted;
more preferably, the deuterium donor reagent is heavy water (D)2O)。
4. The method for synthesizing α, α -dideuterol compounds represented by the general formula (2) according to claim 1, wherein the divalent lanthanide transition metal compound is one or a combination of two or more selected from the group consisting of a divalent samarium compound, a divalent dysprosium compound, a divalent neodymium compound, a divalent ytterbium compound, a divalent cerium compound, and a divalent europium compound;
preferably, the divalent lanthanide transition metal compound is selected from samarium diiodide (SmI)2) Dysprosium diiodide (DyI)2) Neodymium diiodide (NdI)2) Ytterbium diiodide (YbI)2) Cerium diiodide (CeI)2) And europium (II) perchlorate (Eu (ClO)4)2) One or a combination of two or more of them;
preferably, the divalent lanthanide transition metal compound is samarium diiodide (SmI)2)。
5. The method for synthesizing α, α -dideuterol compounds represented by general formula (2) according to claim 1, wherein the organic solvent I is one or a combination of two or more selected from the group consisting of small-molecule alkanes, cycloalkanes, aromatic hydrocarbons, ethers, and cyclic ether solvents;
preferably, the organic solvent I is one or a combination of more than two of n-hexane, n-pentane, hexane, cyclohexane, toluene, diethyl ether, tetrahydrofuran, 2-methyltetrahydrofuran and dioxane;
preferably, the organic solvent I is tetrahydrofuran.
6. The method for synthesizing α, α -dideuterol compounds represented by general formula (2) according to claim 1, wherein the ratio of organic solvent I to acyl fluoride compound is 1 mL: 1-300 mg.
7. The method for synthesizing α, α -dideuterol compounds represented by general formula (2) according to claim 1, wherein the reaction temperature is-40 to 60 ℃; the reaction time is 0.1-60 min.
8. Deuterated cinacalcet and deuterated 2, 4-D-2-ethylhexyl ester synthesized by using alpha, alpha-dideuterol compounds shown as a general formula (2) as raw materials.
9. The compound of the general formula (2) prepared by the synthesis method using the α, α -dideuterol compound as the raw material according to claims 1 to 7, preferably the compound of the following specific general formula (2):
Figure FDA0003024805700000031
CN202110412855.5A 2021-04-16 2021-04-16 Method for synthesizing alpha, alpha-dideuterol and deuterated drugs by reducing and deuterating acyl fluoride compounds Pending CN113292393A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110412855.5A CN113292393A (en) 2021-04-16 2021-04-16 Method for synthesizing alpha, alpha-dideuterol and deuterated drugs by reducing and deuterating acyl fluoride compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110412855.5A CN113292393A (en) 2021-04-16 2021-04-16 Method for synthesizing alpha, alpha-dideuterol and deuterated drugs by reducing and deuterating acyl fluoride compounds

Publications (1)

Publication Number Publication Date
CN113292393A true CN113292393A (en) 2021-08-24

Family

ID=77318826

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110412855.5A Pending CN113292393A (en) 2021-04-16 2021-04-16 Method for synthesizing alpha, alpha-dideuterol and deuterated drugs by reducing and deuterating acyl fluoride compounds

Country Status (1)

Country Link
CN (1) CN113292393A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114773174A (en) * 2022-04-29 2022-07-22 常州大学 Synthetic method of alpha-deuterated carbonyl compound

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008122010A1 (en) * 2007-04-02 2008-10-09 Concert Pharmaceuticals, Inc. Pharmaceutical calcimimetics
CN107445798A (en) * 2016-06-01 2017-12-08 中国农业大学 A kind of synthetic method of the deuterated alcohol compound of α, α-two
CN111499492A (en) * 2019-01-31 2020-08-07 中化近代环保化工(西安)有限公司 Preparation method of 2, 2-difluoroethanol

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008122010A1 (en) * 2007-04-02 2008-10-09 Concert Pharmaceuticals, Inc. Pharmaceutical calcimimetics
CN107445798A (en) * 2016-06-01 2017-12-08 中国农业大学 A kind of synthetic method of the deuterated alcohol compound of α, α-two
CN111499492A (en) * 2019-01-31 2020-08-07 中化近代环保化工(西安)有限公司 Preparation method of 2, 2-difluoroethanol

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HENGZHAO LI等: ""Pentafluorophenyl Esters: Highly Chemoselective Ketyl Precursors for the Synthesis of α,α-Dideuterio Alcohols Using SmI2 and D2O as a Deuterium Source"", 《ORG. LETT.》 *
MICHAL SZOSTAK等: ""Selective Synthesis of α,α-Dideuterio Alcohols by the Reduction of Carboxylic Acids Using SmI2 and D2O as Deuterium Source under SET Conditions"", 《ORG. LETT.》 *
SYED R. HUQ等: ""Mechanistic Study of SmI2/H2O and SmI2/Amine/H2O‑Promoted Chemoselective Reduction of Aromatic Amides (Primary, Secondary,Tertiary) to Alcohols via Aminoketyl Radicals"", 《J. ORG. CHEM.》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114773174A (en) * 2022-04-29 2022-07-22 常州大学 Synthetic method of alpha-deuterated carbonyl compound
CN114773174B (en) * 2022-04-29 2024-05-28 常州大学 Synthesis method of alpha-deuterated carbonyl compound

Similar Documents

Publication Publication Date Title
CN112430187B (en) Alpha, beta-deuterated amine compound, deuterated drug and preparation method thereof
CN107445798B (en) Synthetic method of alpha, alpha-dideuteroalcohol compound
CN109400501B (en) Functionalized pillar arene derivative and preparation method thereof
CN113061077B (en) Alpha, alpha-dideuteroalcohol compounds, deuterated drugs and preparation method thereof
CN113292393A (en) Method for synthesizing alpha, alpha-dideuterol and deuterated drugs by reducing and deuterating acyl fluoride compounds
CN116063223A (en) 10-perfluoroalkyl-5, 10-indano [1,2-b ] indole compound and synthesis method thereof
CN116283899A (en) 3-perfluoroalkyl benzothiophene [ b ] cyclopentenone compound and synthesis method thereof
CN112279772A (en) Alpha, alpha-dideuteroamine compound, deuterated drug and preparation method thereof
CN113354513A (en) Alpha, alpha-dideuterobenzyl alcohol compound, deuterated drug and reduction deuteration method of benzoate compound
CN115785135B (en) Polysubstituted prenyl borate and synthesis method thereof
CN113563147B (en) Method for selectively deuterating aromatic ring benzyl hydrocarbon bond
CN112939732A (en) Synthesis method of alpha-deuterated alcohol compound and deuterated drug
CN112851520B (en) Alpha-deuterated amine compound, deuterated drug and preparation method thereof
CN114920897A (en) Two deuterated polymers and preparation method thereof
CN111217847B (en) Thiosilane ligand, preparation method thereof and application thereof in aryl boronization catalytic reaction
CN112679312A (en) Alpha, alpha-dideuterol compound and preparation method thereof
CN114907246A (en) Total synthesis method of vitamin A, derivative thereof and deuterated compound thereof
JPWO2008066158A1 (en) Deuteration of alkanes
CN114213440B (en) 2-boron alkenyl oxygen ether compound and preparation method thereof
CN113754578B (en) Synthesis method 15 Method for N-labelling aromatic amines
CN114805674B (en) Polymeric phosphine ligands, transition metal complexes comprising same, preparation and use thereof
CN113620795B (en) Method for synthesizing benzocycloheptenone compounds
CN109265352B (en) Preparation method of aryl cyclopropyl ether and derivatives thereof
CN115057774A (en) Alpha-deuterated carboxylic acid derivative compound and synthetic method of deuterated drug
CN114891034A (en) TML type trigger molecule and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210824

RJ01 Rejection of invention patent application after publication